24 April 2020 ORYZON to initiate ESCAPE: a Phase II clinical trial to test efficacy of vafidemstat in severely ill COVID-19 patients
3 April 2020 ORYZON presents efficacy data from its two vafidemstat clinical trials in Alzheimer’s disease at the virtual AAT-AD/PD 2020 Conference
4-5 February 2020 6th Annual LSX World Congress 2020 133 Houndsditch, Liverpool St London United Kingdom